Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 200...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/9/1/25 |
_version_ | 1827666211461136384 |
---|---|
author | Miriam Moreno-Ramos Mercedes Sánchez-Barba Rubén García Sánchez José Antonio Mirón-Canelo Veronica González-Nuñez |
author_facet | Miriam Moreno-Ramos Mercedes Sánchez-Barba Rubén García Sánchez José Antonio Mirón-Canelo Veronica González-Nuñez |
author_sort | Miriam Moreno-Ramos |
collection | DOAJ |
description | Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 2000 to 2019. Methodology: Data of NAS cases in Castilla y León from 2000 to 2019 were obtained. NAS incidence per 1000 births was calculated and the correlation among data from different provinces and years was analyzed. Results: The cumulative incidence of NAS in Castilla y León per 1000 births between 2000-2019 was 0.91‰, with great interprovincial variability. The provinces of Zamora and Palencia stand out, with high incidence rates of NAS despite their low birth rates. The temporal trend points towards a decrease in incidence from 2000 to 2019. Opioids such as methadone, cannabis, benzodiazepines and poly-drug use are the most prevalent drugs causing NAS, and it has also been observed that methadone is being replaced by cannabis as the major cause of NAS cases at the University Hospital in Salamanca in recent years. Conclusions: The incidence of NAS in Castilla y León decreased in 2004 and remained constant until 2019, but it shows great interprovincial variability. It is necessary to implement a national NAS Registry to obtain comprehensive information regarding its incidence. |
first_indexed | 2024-03-10T01:43:43Z |
format | Article |
id | doaj.art-e18a271273cc4c2791f51d758605b740 |
institution | Directory Open Access Journal |
issn | 2227-9067 |
language | English |
last_indexed | 2024-03-10T01:43:43Z |
publishDate | 2021-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Children |
spelling | doaj.art-e18a271273cc4c2791f51d758605b7402023-11-23T13:20:38ZengMDPI AGChildren2227-90672021-12-01912510.3390/children9010025Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)Miriam Moreno-Ramos0Mercedes Sánchez-Barba1Rubén García Sánchez2José Antonio Mirón-Canelo3Veronica González-Nuñez4Faculty of Medicine, University of Salamanca, 37008 Salamanca, SpainDepartment of Statistics, Faculty of Medicine, University of Salamanca, 37008 Salamanca, SpainDepartment of Pediatrics, University Hospital of Salamanca, 37008 Salamanca, SpainInstitute of Biomedical and Diagnostic Sciences (IBSAL), 37007 Salamanca, SpainInstitute of Biomedical and Diagnostic Sciences (IBSAL), 37007 Salamanca, SpainIntroduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 2000 to 2019. Methodology: Data of NAS cases in Castilla y León from 2000 to 2019 were obtained. NAS incidence per 1000 births was calculated and the correlation among data from different provinces and years was analyzed. Results: The cumulative incidence of NAS in Castilla y León per 1000 births between 2000-2019 was 0.91‰, with great interprovincial variability. The provinces of Zamora and Palencia stand out, with high incidence rates of NAS despite their low birth rates. The temporal trend points towards a decrease in incidence from 2000 to 2019. Opioids such as methadone, cannabis, benzodiazepines and poly-drug use are the most prevalent drugs causing NAS, and it has also been observed that methadone is being replaced by cannabis as the major cause of NAS cases at the University Hospital in Salamanca in recent years. Conclusions: The incidence of NAS in Castilla y León decreased in 2004 and remained constant until 2019, but it shows great interprovincial variability. It is necessary to implement a national NAS Registry to obtain comprehensive information regarding its incidence.https://www.mdpi.com/2227-9067/9/1/25Neonatal Abstinence Syndrome (NAS)substance use disorderopiatesCastilla y Leóncorrelational researchbiplot |
spellingShingle | Miriam Moreno-Ramos Mercedes Sánchez-Barba Rubén García Sánchez José Antonio Mirón-Canelo Veronica González-Nuñez Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain) Children Neonatal Abstinence Syndrome (NAS) substance use disorder opiates Castilla y León correlational research biplot |
title | Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain) |
title_full | Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain) |
title_fullStr | Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain) |
title_full_unstemmed | Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain) |
title_short | Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain) |
title_sort | incidence of neonatal abstinence syndrome nas in castilla y leon spain |
topic | Neonatal Abstinence Syndrome (NAS) substance use disorder opiates Castilla y León correlational research biplot |
url | https://www.mdpi.com/2227-9067/9/1/25 |
work_keys_str_mv | AT miriammorenoramos incidenceofneonatalabstinencesyndromenasincastillayleonspain AT mercedessanchezbarba incidenceofneonatalabstinencesyndromenasincastillayleonspain AT rubengarciasanchez incidenceofneonatalabstinencesyndromenasincastillayleonspain AT joseantoniomironcanelo incidenceofneonatalabstinencesyndromenasincastillayleonspain AT veronicagonzaleznunez incidenceofneonatalabstinencesyndromenasincastillayleonspain |